2026 Isabelle Sermet-Gaudelus: Molecular Biology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Molecular Biology	59	2006	1803	70	56	202	15904

Overview

Isabelle Sermet-Gaudelus is affiliated with Necker-Enfants Malades Hospital in France and has contributed extensively to the field of medicine, focusing primarily on pulmonary and respiratory medicine. Their research spans multiple subfields including molecular biology, infectious diseases, epidemiology, and genetics, with a particular emphasis on cystic fibrosis and respiratory disorders in pediatric populations.

The scientist's publication record includes over 335 works in medicine, with significant contributions to journals such as the Journal of Cystic Fibrosis, where they have published 81 papers, bioRxiv (Cold Spring Harbor Laboratory) with 12 publications, and the European Respiratory Journal featuring 7 articles. Other frequent venues include The Lancet Respiratory Medicine and the International Journal of Molecular Sciences.

Research topics most commonly addressed by Isabelle Sermet-Gaudelus include:

Cystic Fibrosis Research Advances
Neonatal Respiratory Health Research
Tracheal and airway disorders
Pediatric health and respiratory diseases
Asthma and respiratory diseases
Respiratory viral infections research
Inhalation and Respiratory Drug Delivery

Frequent co-authors in their work include Philippe Reix, Iwona Pranke, Alexandre Hinzpeter, Aurélie Hatton, and Pierre-Régis Burgel. These collaborations have contributed to an extensive body of work advancing the understanding and treatment of respiratory and genetic disorders related to cystic fibrosis.

Some recent publications by Isabelle Sermet-Gaudelus include:

"Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study," 2020, The Lancet Child & Adolescent Health
"Impact of COVID-19 on people with cystic fibrosis," 2020, The Lancet Respiratory Medicine
"A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis," 2020, Journal of Cystic Fibrosis
"Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)," 2020, Journal of Cystic Fibrosis
"Airway Surface Liquid pH Regulation in Airway Epithelium Current Understandings and Gaps in Knowledge," 2021, International Journal of Molecular Sciences

Best Publications

A CFTR potentiator in patients with cystic fibrosis and the G551D mutation

Bonnie W. Ramsey;Jane Davies;N. Gerard McElvaney;Elizabeth Tullis

2384
Citations
Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation

Philip M. Farrell;Terry B. White;Clement L. Ren;Sarah E. Hempstead

877
Citations
SLC34A3 Mutations in Patients with Hereditary Hypophosphatemic Rickets with Hypercalciuria Predict a Key Role for the Sodium-Phosphate Cotransporter NaPi-IIc in Maintaining Phosphate Homeostasis

Clemens Bergwitz;Nicole M. Roslin;Martin Tieder;J.C. Loredo-Osti

591
Citations
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis

R. Andres Floto;R. Andres Floto;Kenneth N. Olivier;Lisa Saiman;Charles L. Daley

540
Citations
Recommendations for the classification of diseases as CFTR-related disorders

Cristina Bombieri;M Claustres;K De Boeck;N Derichs

459
Citations
Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial

Eitan Kerem;Michael W Konstan;Kris De Boeck;Frank J Accurso

352
Citations
European best practice guidelines for cystic fibrosis neonatal screening

Carlo Castellani;Kevin W. Southern;Keith Brownlee;Jeannette Dankert Roelse

319
Citations
Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis

Unknown

282
Citations
Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)

Edward F McKone;Drucy Borowitz;Pavel Drevinek;Matthias Griese;Matthias Griese

228
Citations
European cystic fibrosis bone mineralisation guidelines.

Isabelle Sermet-Gaudelus;Maria Luisa Bianchi;Michèle Garabédian;Robert M. Aris

206
Citations
In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study

Isabelle Sermet-Gaudelus;Isabelle Sermet-Gaudelus;Michel Renouil;Anne Fajac;Laure Bidou;Laure Bidou

190
Citations
Age-Related Prevalence and Distribution of Nontuberculous Mycobacterial Species among Patients with Cystic Fibrosis

Catherine Pierre-Audigier;Agnès Ferroni;Isabelle Sermet-Gaudelus;Muriel Le Bourgeois

173
Citations
Mycobacterium abscessus and children with cystic fibrosis.

Isabelle Sermet-Gaudelus;Muriel Le Bourgeois;Catherine Pierre-Audigier;Catherine Offredo

171
Citations
Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis.

Unknown

149
Citations
Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity

Erwan Pernet;Erwan Pernet;Erwan Pernet;Laurent Guillemot;Laurent Guillemot;Pierre-Régis Burgel;Clémence Martin

149
Citations
Impact of COVID-19 on people with cystic fibrosis.

Unknown

144
Citations
New clinical diagnostic procedures for cystic fibrosis in Europe

K. De Boeck;N. Derichs;I. Fajac;H.R. de Jonge

143
Citations
Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators

Iwona M. Pranke;Aurélie Hatton;Juliette Simonin;Jean Philippe Jais

141
Citations
Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis

Unknown

133
Citations
The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening

Thauvin-Robinet C;Munck A;Huet F;Génin E

131
Citations

Frequent Co-Authors

Aleksander Edelman Université Paris Cité

Patrick Berche Université Paris Cité

Jean-Louis Gaillard Hôpital Ambroise-Paré

Steven M. Rowe University of Alabama at Birmingham

J. Stuart Elborn Queen's University Belfast

Véronique Witko-Sarsat Inserm

Claire E. Wainwright University of Queensland

Michael W. Konstan Case Western Reserve University

Felix Ratjen University of Toronto

Xavier Nassif Université Paris Cité

External Links

Personal website of Isabelle Sermet-Gaudelus

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For students interested in Molecular Biology, related online degrees such as nursing or health sciences can open diverse career pathways. Selecting the best program is essential, especially with the wide range of online options available. Students often compare wgu vs chamberlain to find flexible, reputable RN-to-BSN pathways that fit their personal schedules.

Those pursuing advanced roles may benefit from bsn to msn bridge programs, which offer an accelerated route to specialized positions in research or healthcare management. Choosing a non profit university can provide additional confidence in the program’s accreditation and affordability.

If you’re active military or a veteran, selecting an online college for military ensures additional support and benefits. Ultimately, the right degree pathway can help you build a rewarding career in scientific research, academia, or industry settings related to molecular biology.